Patent · US Active

RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control

US11608502B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 20, 2020
Grant dateMar 21, 2023
Priority date
Expiry dateAug 20, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldBasic materials chemistry
  • WIPO sectorChemistry

Abstract

The invention belongs to the field of genetic engineering technology and application thereof, and in order to solve the problems of lack of high efficient TMV-resistant RNAi nano-preparation at present, complicated preparation process of medicament, poor stability and delivery efficiency of dsRNA, the invention provides an RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control. The RNAi nano-preparation is prepared from dsRNA and chitosan nano materials, wherein, dsRNA is a highly TMV-resistant RdRP3 gene with a length of 313 bp obtained from screening, with nucleotide sequence shown in SEQ ID NO.1, and the volume ratio of the chitosan to 1 μg/μl dsRNA is 10:(1-6). The RNAi nano-preparation provided by the invention has the advantages of stronger stability and better durability of dsRNA, good biocompatibility, good biodegradability, no harm to crops, environmental friendliness and the like, and has a good application prospect in the field of TMV virus prevention and control.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.